DJIA 16,058.35 -469.68 -2.84%
NASDAQ 4,636.11 -140.40 -2.94%
S&P 500 1,913.85 -58.33 -2.96%
market minute promo

47.05 0.67 (1.44%)

REAL-TIME: Last trade at

Extended Hours: $47.05 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

NBIX $47.05 1.44%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $45.27
Previous Close $46.38
Daily Range $45.06 - $48.02
52-Week Range $15.10 - $56.18
Market Cap $4.0B
P/E Ratio -61.03
Dividend (Yield) $0.00 (0.0%)
Volume 930,126
Average Daily Volume 718,516
Current FY EPS -$0.88

Sector

Healthcare

Industry

Drug Makers

Neurocrine Biosciences, Inc. (NBIX) Description

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis. Website: http://www.neurocrine.com/

News & Commentary

NBIX's Top Competitors

NBIX $47.05 (1.44%)
Current stock: NBIX
AMGN $147.46 (-2.85%)
Current stock: AMGN
GILD $101.49 (-3.41%)
Current stock: GILD
BIIB $292.50 (-1.61%)
Current stock: BIIB